Results 301 to 310 of about 68,339 (362)

Recognition and Management of Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Implications of Clinical Confidence. [PDF]

Medicina (Kaunas)
Siraj RA.
europepmc   +1 more source

Design method of a bidirectional flow meter for a metered dose inhaler

Péter Sáfrány, Attila Kerekes, Csaba Hős   +2 more
openalex   +1 more source

Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate After Dual and Triple Therapy in Spain: A Sub-Study of the ORESTES Study. [PDF]

Pulm Ther
Figueira-Gonçalves JM, Alcázar-Navarrete B, Casitas-Mateo R, González J, Gotera-Rivera CM, Herrejón-Silvestre A, Margallo-Iribarnegaray J, Martín-Lana M, Pallarés-Sanmartín A, Pascual-Guardia S, Saura-Vinuesa A, Corregidor-García C, Fitas E, Sánchez-Covisa J.   +13 more
europepmc   +1 more source

Inhaler use and their carbon footprint in Germany: a 10-year analysis (2013-2022). [PDF]

BMJ Open Respir Res
Blau S, Mücke M, Hesse M, Sellin J, Gradl G, Schulz M, Ateş G.   +6 more
europepmc   +1 more source

Clinical impact of disease stability on exacerbation and mortality in COPD: a retrospective cohort study. [PDF]

Ann Med
Kim SH, Lee JK, Min KH, Kim DK, Lee HW.
europepmc   +1 more source

A Longitudinal Assessment of Greenhouse Gas Emissions From Inhaler Devices in a National Health System. [PDF]

JAMA
Weppner WG, Singh H, Boyd J, Smith G, Chesebro BB.   +4 more
europepmc   +1 more source

Fluticasone- vs Budesonide-Based Dual Therapy for COPD.

JAMA Netw Open
Feldman WB, Ambati VL, Suissa S, Kesselheim AS, Avorn J, Schneeweiss S, Wang SV.   +6 more
europepmc   +1 more source

Contextual Assessments for Chronic Obstructive Pulmonary Disease Transition of Care Bundle Implementation Planning for the Reduce REVISITS Study: Rapid Sequential Explanatory Mixed Methods Approach.

JMIR Hum Factors
Akula M, Erwin K, Traeger L, Pick H, Gao F, Damschroder L, Press VG.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Inhalants

Critical Care Clinics, 2021
Toxic inhalants include various xenobiotics. Irritants cause upper and lower respiratory tract injuries. Highly water-soluble agents injure the upper respiratory tract, while low water-soluble inhalants injure the lower track. Asphyxiants are divided into simple asphyxiants and chemical asphyxiants.
openaire   +2 more sources